Cancer researchers collaborate, target DNA damage repair pathways for cancer therapy
MIT researchers find blocking the expression of the genes XPA and MK2 enhances the tumor-shrinking effects of platinum-based chemotherapies in p53-mutated cancers.
MIT researchers find blocking the expression of the genes XPA and MK2 enhances the tumor-shrinking effects of platinum-based chemotherapies in p53-mutated cancers.
Molecular biologist and professor emerita advocates for more inclusive science and advises how to get there.
MIT professor announced as award’s first recipient for work in cancer diagnosis and drug synthesis.
MIT engineers devise a temporary film that may help treat diabetes, infections, and other conditions.
The experimental drug has shown promise in early-stage clinical trials conducted in Singapore.
Study finds “epigenomic” alterations evolve as lung tumors become more aggressive and metastasize.
Specialized nanoparticles create a “breath signal” that could be used to diagnose pneumonia and other infectious or genetic diseases.
A new computational method fine-tunes delivery of therapeutics to specific brain regions.
The prototype mask, which includes an N95 filter, can be easily sterilized and worn many times.
MIT engineers are using computing modeling to prevent microparticles from clogging during injections.
In lab tests, virus-like DNA structures coated with viral proteins provoke a strong immune response in human B cells.
Certain cancer therapeutics concentrate within cells — a finding that could change the way scientists think about drug design.
New molecule for imaging calcium in neurons reduces crosstalk from neighboring neurons.
A new platform that precisely quantifies antigens presented on cell surfaces may help researchers and clinicians improve the effectiveness of cancer immunotherapies.
Engineers design nanoparticles that stimulate the immune system, helping it to attack tumors.